• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
DN8
Click for more information
0.00% 26.5¢

DREAMSCAPE NETWORKS LIMITED

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
DN8
Ann: Joint Company Secretary Appointment 		05/03/19 0 249
05/03/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  249 
DN8
Ann: Half Year Results Update 		26/02/19 19 3.7K
26/02/19 Last post  viperofpitstorm Comments Created with Sketch.  19  Views Created with Sketch.  3.7K 
DN8
Ann: A Significant Improvement in Results, Executing on Plan 		22/02/19 1 316
22/02/19 Last post  Icarus Comments Created with Sketch.  1  Views Created with Sketch.  316 
DN8
Ann: Half Year Presentation H1FY19 		22/02/19 0 186
22/02/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  186 
DN8
Ann: Half Yearly Report and Accounts 		22/02/19 0 226
22/02/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  226 
DN8
News: DN8 Dreamscape Networks Sees H1 Adjusted EBITDA In Range Of $4.8 Mln To $5.0 Mln 		25/01/19 0 179
25/01/19 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  179 
DN8
Ann: Trading Update 		21/01/19 12 2.3K
21/01/19 Last post  DirkKyut Comments Created with Sketch.  12  Views Created with Sketch.  2.3K 
DN8
Vodien services 		31/12/18 15 3.1K
31/12/18 Last post  valvesound Comments Created with Sketch.  15  Views Created with Sketch.  3.1K 

See All Discussions arrow Created with Sketch.

Top Stories

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks Copper prices slump; Trump Wall Street rally fades; US health stocks dip on RFK appointment – and much more.
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play Empire Energy (ASX:EEG) has confirmed the NT government has delivered environmental approvals for Carpentaria.
Cyclone signs MOU with Vale for development of Iron Bear play Cyclone Metals Lt has signed a Memorandum of Understanding with Vale S.A to support development of the former's iron ore project in Canada
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.